Alphatec Announces Participation at Stifel 2018 Healthcare Conference
October 31 2018 - 9:05AM
Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a
provider of innovative spine surgery solutions with a mission to
improve patient lives through the relentless pursuit of superior
outcomes, today announced it will present at the Stifel 2018
Healthcare Conference on November 14, 2018, at 2:00 P.M. EST at the
Lotte New York Palace Hotel.
Terry Rich, ATEC’s President and Chief Operating
Officer, will provide a business overview of the during the live
presentation. Management will also be available to participate in
one-on-one meetings with investors who are registered to attend the
conference.
A copy of the presentation will be available
online from the investor relations page of the Company's corporate
website at www.atecspine.com. The conference will be webcast live.
To access the webcast, please visit
http://wsw.com/webcast/stifel14/atec/. The webcast
replay will remain available for 90 days following the live
presentation.
About Alphatec Holdings,
Inc.
Alphatec Holdings, Inc., through its
wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp
Surgical, Inc., is a medical device company that designs, develops
and markets spinal fusion technology products and solutions for the
treatment of spinal disorders associated with disease and
degeneration, congenital deformities, and trauma. The Company's
mission is to improve lives by providing innovative spine surgery
solutions through the relentless pursuit of superior outcomes. The
Company markets its products in the U.S. via independent sales
agents and a direct sales force.
Additional information can be found at
www.atecspine.com
Forward-Looking Statements
Statements made in this press release and made
during the investor events referenced herein may contain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 that involve risks and
uncertainty. Such statements are based on management's current
expectations and are subject to a number of risks and uncertainties
that could cause actual results to differ materially from those
described in the forward-looking statements. The Company cautions
investors that there can be no assurance that actual results or
business conditions will not differ materially from those projected
or suggested in such forward-looking statements as a result of
various factors. Forward-looking statements include the references
to the Company’s strategy in significantly repositioning the ATEC
brand and turning the Company into a growth organization. The
important factors that could cause actual operating results to
differ significantly from those expressed or implied by such
forward-looking statements include, but are not limited
to: the uncertainty of success in developing new
products or products currently in the Company’s pipeline; the
uncertainties in the Company’s ability to execute upon its
strategic operating plan; the uncertainties regarding the ability
to successfully license or acquire new products, and the commercial
success of such products; failure to achieve acceptance of the
Company’s products by the surgeon community; failure to obtain FDA
or other regulatory clearance or approval for new products, or
unexpected or prolonged delays in the process; continuation of
favorable third party reimbursement for procedures performed using
the Company’s products; unanticipated expenses or liabilities or
other adverse events affecting cash flow or the Company’s ability
to successfully control its costs or achieve profitability;
uncertainty of additional funding; the Company’s ability to compete
with other competing products and with emerging new technologies;
product liability exposure; an unsuccessful outcome in any
litigation in which the Company is a defendant; patent infringement
claims; claims related to the Company’s intellectual property and
the Company’s ability to meet its financial obligations under its
credit agreements and the OrthoTec, LLC settlement agreement. The
words “believe,” “will,” “should,” “expect,” “intend,” “estimate”
and “anticipate,” variations of such words and similar expressions
identify forward-looking statements, but their absence does not
mean that a statement is not a forward-looking statement. A further
list and description of these and other factors, risks and
uncertainties can be found in the Company's most recent annual
report, and any subsequent quarterly and current reports, filed
with the Securities and Exchange Commission. ATEC disclaims
any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, unless required by law.
Investor/Media Contact:
Tina Jacobsen ir@atecspine.com(760) 494-6790
Company Contact:
Jeff BlackExecutive Vice President and Chief Financial
OfficerAlphatec Holdings, Inc.ir@atecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2023 to Apr 2024